Kane Biotech Inc. (TSXV:KNE)
Canada · Delayed Price · Currency is CAD 0.0300
0.00 (0.00%)
At close: Mar 20, 2026
Kane Biotech Market Cap
Kane Biotech has a market cap or net worth of CAD 5.46 million as of March 20, 2026. Its market cap has decreased by -67.05% in one year.
Market Cap
5.46M
Enterprise Value
6.81M
Revenue
574.87K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since May 20, 2003, Kane Biotech's market cap has increased from 1.03M to 5.46M, an increase of 430.53%. That is a compound annual growth rate of 7.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 5.46M | -24.79% |
| Dec 30, 2025 | 7.25M | -52.04% |
| Dec 31, 2024 | 15.13M | 43.41% |
| Dec 29, 2023 | 10.55M | -6.12% |
| Dec 30, 2022 | 11.23M | -36.87% |
| Dec 31, 2021 | 17.80M | 17.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaTher Holdings | 6.37M |
| Restart Life Sciences | 6.22M |
| Aptose Biosciences | 5.67M |
| MYND Life Sciences | 5.22M |
| Quest PharmaTech | 5.07M |
| COSCIENS Biopharma | 4.78M |
| XORTX Therapeutics | 4.46M |
| MindBio Therapeutics | 4.27M |